TCRT - Alaunos Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Alaunos Therapeutics's activity chart (see below) currently has 20 price targets and 25 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 48.97% of the time, taking 268.54 days on average.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 16-Aug-2023.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Aug-2023

$225

3 years 3 months 2 days ago
(16-Aug-2023)

2/4 (50%)

$127.5 (130.77%)

318

Hold Since 16-Aug-2023

$30

3 years 3 months 3 days ago
(16-Aug-2023)

0/1 (0%)

$6 (25.00%)

Buy Since 04-Oct-2022

$450

$450

3 years 8 months 10 days ago
(08-Mar-2023)

0/2 (0%)

$360 (400.00%)

Buy Since 04-Apr-2019

$525

4 years 2 months 2 days ago
(16-Sep-2022)

1/2 (50%)

$237 (82.29%)

394

Buy Since 15-Jul-2022

$450

4 years 4 months 4 days ago
(15-Jul-2022)

1/1 (100%)

$252 (127.27%)

48

Show more analysts

Please expand the browser size to see the chart

What is TCRT (Alaunos Therapeutics) average time for price targets to be met?

On average it took 269 days for the stock forecasts to be reached, with an average price target met ratio of 48.97%.

Which analyst most recently updated their price target on TCRT (Alaunos Therapeutics)?

Swayampakula Ramakanth

Which analyst has the most public recommendations on TCRT (Alaunos Therapeutics)?

Swayampakula Ramakanth has 10 price targets and 8 ratings on TCRT

Which analyst is the currently most bullish on TCRT (Alaunos Therapeutics)?

Jim Birchenough with the highest potential upside of $2247.92

Which analyst is the currently most reserved on TCRT (Alaunos Therapeutics)?

Thomas Flaten with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?